The association of five preoperative serum tumor markers and pathological features in patients with breast cancer
The association of five preoperative serum tumor markers and pathological features in patients with breast cancer
复制标题
乳腺癌患者术前5种血清肿瘤标志物与病理特征的关系
DOI：
10.1002/jcla.22875
复制
发表时间：
2019-06-01
影响因子：
2.7
通讯作者：
Hong, Guolin
中科院分区：
文献类型：
--
作者：
Lian, Mingjian;Zhang, Cuixia;Hong, Guolin
常用的血清肿瘤标志物在乳腺癌中的应用仍然存在争议。本研究旨在探讨术前癌胚抗原（CEA）、癌抗原125 （CA125）、癌抗原153 （CA153）、癌抗原724 （CA724）、铁蛋白（FER）在乳腺癌治疗中的作用及其与病理特征的关系。
The utility of frequently used serum tumor markers in breast cancer remains controversial. The study aimed to investigate the role of preoperative carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), cancer antigen 153 (CA153), cancer antigen 724 (CA724), and ferritin (FER) in the management of breast cancer and their relationships with pathological features.